5-amino-1mq fda approval status Peptide Dosing Guide: Oral Protocol, Reconstitution & Safety (2026) 5-Amino-1MQ | NNMT Inhibitor

Field 6: Route 5-Amino-1MQ : oral capsule, by design (built to be membrane-permeable and orally taken)

In those patients, addressing the underlying metabolic dysfunction first, through dietary intervention, GLP-1 therapy if indicated, or NAD+ support for cellular energy metabolism, is the clinical priority

Oral supplements, on the other hand, require ingestion and absorption through the digestive system

In naturally aged mouse models (1820 months old), daily oral administration of 5-amino-1mq capsules for 12 consecutive weeks significantly reduced NNMT activity and increased NAD+ levels in various tissues (liver, kidney, adipose tissue), along with markedly elevated expression of SIRT1 and SIRT3 proteins

Bone and musculoskeletal research: Some work has extended into bone repair and osteoporosis models, where AOD9604 has shown early signs of supporting bone remodeling, though this area is less developed than its fat metabolism and cartilage research